Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human PML Antikörper:
anti-Mouse (Murine) PML Antikörper:
anti-Rat (Rattus) PML Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal PML Primary Antibody für ICC, IF - ABIN252967
Wimmer, Schreiner, Everett, Sirma, Groitl, Dobner: SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. in Oncogene 2010
Show all 21 Pubmed References
Human Polyclonal PML Primary Antibody für ICC, IF - ABIN4346484
Campagna, Herranz, Garcia, Marcos-Villar, González-Santamaría, Gallego, Gutierrez, Collado, Serrano, Esteban, Rivas: SIRT1 stabilizes PML promoting its sumoylation. in Cell death and differentiation 2010
Show all 3 Pubmed References
Human Polyclonal PML Primary Antibody für ELISA, WB - ABIN1583526
Kolegraff, Nava, Helms, Parkos, Nusrat: Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/?-catenin signaling. in Molecular biology of the cell 2011
Show all 2 Pubmed References
Human Polyclonal PML Primary Antibody für ICC, IF - ABIN252968
Kuroki, Ariumi, Ikeda, Dansako, Wakita, Kato: Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. in Journal of virology 2009
Show all 2 Pubmed References
Mouse (Murine) Monoclonal PML Primary Antibody für ICC, IF - ABIN2668256
Evdokimov, Sharma, Lockett, Lualdi, Kuehn: Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. in Journal of cell science 2008
Our findings unveil a novel essential oncogenic activity of PML/RARA (zeige RARA Antikörper) in Acute promyelocitic leukemia
Findings reveal a previously unrecognized role of c-Myc (zeige MYC Antikörper) as a potential ceRNA for PML/RARalpha (zeige RARA Antikörper) in acute promyelocytic leukemia.
PML loss promotes tumor development, providing a growth advantage to tumor cells that use autophagy as a cell survival strategy during stress conditions.
WDR4 (zeige WDR4 Antikörper) is an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment
Sumoylation of PML with SUMO2 (zeige SUMO2 Antikörper) by UBC9/UBE2I (zeige UBE2I Antikörper) can lead to formation of polymeric SUMO chains. Data suggest that coordination of growing poly-SUMO chain with "back side" binding site on UBC9/UBE2I (zeige UBE2I Antikörper) appears to be required for SUMO chain elongation on PML. (PML = promyelocytic leukemia protein; SUMO2 (zeige SUMO2 Antikörper) = small ubiquitin-like modifier 2 (zeige SUMO2 Antikörper); UBC9/UBE2I (zeige UBE2I Antikörper) = ubiquitin-conjugating enzyme (zeige Ube2t Antikörper) UBC9/UBE2I (zeige UBE2I Antikörper))
Data show that the cytoplasmic localization of promyelocytic leukaemia (PML) is mediated by its nuclear export in a chromosomal maintenance 1 (CRM1 (zeige XPO1 Antikörper))-dependent manner.
this study, we first observed that PML-positive intranuclear aggregates also appeared in controls and were not specific for the Neuronal Intranuclear Hyaline Inclusion Disease cases.
TRIB3 (zeige TRIB3 Antikörper) promotes acute promyelocytic leukemia progression through stabilization of the oncoprotein PML-RARalpha (zeige RARA Antikörper) and inhibition of p53 (zeige TP53 Antikörper)-mediated senescence.
Data suggest that the binding of Z-10 to RXRalpha (zeige RXRA Antikörper) inhibited the interaction of RXRalpha (zeige RXRA Antikörper) with PML-RARalpha (zeige RARA Antikörper), leading to Z-10's selective induction of PML-RARalpha (zeige RARA Antikörper) degradation.
PML protein prevents the loss of HPV genome following infection implying that the host cell may be able to recognize chromatinized HPV genome or the associated capsid proteins.
Data indicate that promyelocytic leukemia protein knockout (Pml-/-) animals fail to properly activate oxidative stress-responsive p53 (zeige TP53 Antikörper) targets, whereas the NRF2 (zeige NFE2L2 Antikörper) response is amplified and accelerated.
data support a model in which activation of myogenic differentiation results in PML NB loss, chromatin reorganization and DAXX (zeige DAXX Antikörper) relocalization, and provides a paradigm for understanding the consequence of PML loss in other cellular contexts, such as during cancer development and progression
a regulatory role of ZNF451 (zeige ZNF451 Antikörper)-1 in fine-tuning physiological PML levels
The data demonstrate a dual role of PML in protection and recovery after brain injury.
This study designates PML protein and PML-NBs (zeige NLRP2 Antikörper) to be major cellular components involved in the control of Herpes simplex virus 1 (HSV-1) latency, probably during the entire life of an individual.
Study found that Promyelocytic leukemia protein (PML) is broadly expressed across the gray matter, with the highest levels in the cerebral and cerebellar cortices. PML bodies are broadly involved in activity-dependent nuclear phenomena in adult neurons
These findings suggest that the UBC9/PML/RNF4 axis plays a critical role as an important SUMO pathway in cardiac fibrosis. Modulating the protein levels of the pathway provides an attractive therapeutic target for the treatment of cardiac fibrosis and heart failure.
PML contributes to the intrinsic restriction of HIV-1 infections in a cell type-dependent manner.
both the PML-RARA (zeige RARA Antikörper)-driven competitive transplantation advantage and development of acute promyelocytic leukemia (APL (zeige FASL Antikörper)) required DNMT3A (zeige DNMT3A Antikörper)
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. The gene is often involved in the translocation with the retinoic acid receptor alpha gene associated with acute promyelocytic leukemia (APL). Extensive alternative splicing of this gene results in several variations of the protein's central and C-terminal regions\; all variants encode the same N-terminus. Alternatively spliced transcript variants encoding different isoforms have been identified.
RING finger protein 71
, probable transcription factor PML
, promyelocytic leukemia protein
, promyelocytic leukemia, inducer of
, protein PML
, tripartite motif protein TRIM19
, tripartite motif-containing protein 19
, promyelocytic leukemia
, probable transcription factor PML-like